Sales rise 16.39% to Rs 184.11 crore
Net profit of Supriya Lifescience rose 36.42% to Rs 50.38 crore in the quarter ended March 2025 as against Rs 36.93 crore during the previous quarter ended March 2024. Sales rose 16.39% to Rs 184.11 crore in the quarter ended March 2025 as against Rs 158.18 crore during the previous quarter ended March 2024.For the full year,net profit rose 57.80% to Rs 187.96 crore in the year ended March 2025 as against Rs 119.11 crore during the previous year ended March 2024. Sales rose 22.11% to Rs 696.49 crore in the year ended March 2025 as against Rs 570.37 crore during the previous year ended March 2024.
ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales184.11158.18 16 696.49570.37 22 OPM %36.7135.08 -37.4430.33 - PBDT70.1457.08 23 268.93181.50 48 PBT64.0653.17 20 248.49165.69 50 NP50.3836.93 36 187.96119.11 58
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
